Product class: Medicinal product with marketing authorization
Medicinal product class: Veterinary medicine
Name of medicinal product: Bupaq Multidose
Active substances:
Buprenorphine
Estonian, English, Latin
ATC code: QN02AE01
Dosage form: solution for injection
Strength: 0,3mg 1ml
Legal status for supply*: Prescription for narcotic drugs
Summary of product characteristics (SPC):  (last updated 27 February 2023)
Package information leaflet (PIL): EST  (last updated 22 June 2023)
Labelling:  (last updated 27 February 2023)
Indication: DOG Post-operative analgesia. Potentiation of the sedative effects of centrally-acting agents. CAT Post-operative analgesia.
Safety features: No
Marketing authorization holder: Vetviva Richter GmbH 
Marketing authorization number: 1812 
Marketing authorization issued on: 20 December 2013 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Mutual recognition 
Assessment report:  (last updated 20 December 2013) 
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1622540  Bupaq Multidose  solution for injection  0,3mg 1ml 10ml 1TK      21/11/2023     
1622551  Bupaq Multidose  solution for injection  0,3mg 1ml 10ml 5TK           
1622562  Bupaq Multidose  solution for injection  0,3mg 1ml 10ml 10TK           
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription